THY1 and hepatocellular carcinoma: In summary, the binding of miR-589-5p to the MAP3K8 3ˈ-UTR inhibits MAP3K8 expression and suppresses CD90+ CSC characteristics, and the expression status of CD90 and miR-589-5p determines the behavior of HCC.